Chioma Udemgba1, Adora Lin2. 1. Allergy and Clinical Immunology Fellowship Program, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland. 2. Center for Cancer and Immunology Research, Children's National Research Institute, Washington, DC, USA.
Abstract
PURPOSE OF REVIEW: B cells are known in food allergy pathogenesis for their production of IgE but their roles in the development of tolerance to foods are not well understood. Further understanding of B-cell biology in the context of food allergy is essential for the creation of effective prevention strategies and therapies. RECENT FINDINGS: The majority of allergen-specific IgE in humans appears to arise from antigen-experienced B cells that have already undergone class switch recombination to other antibody isotypes, such as IgG1, and can also be produced by cells class switching to IgE locally in the gastrointestinal tract. Allergen-specific IgG4 can have protective effects in individuals and is associated with tolerance. Regulatory B cells, which can produce allergen-specific IgG4, are reduced in food-allergic individuals and may also be an important component of tolerance. Therapeutic approaches that block the generation and action of IgE and that enhance tolerizing immune responses are being evaluated for the treatment of food allergy. SUMMARY: B cells play several roles in the development of food allergy versus tolerance. Their functions may translate into the care of food allergy as biomarkers or therapeutic targets and can be employed in other atopic diseases to better understand their pathogenesis and create new avenues for treatment.
PURPOSE OF REVIEW: B cells are known in food allergy pathogenesis for their production of IgE but their roles in the development of tolerance to foods are not well understood. Further understanding of B-cell biology in the context of food allergy is essential for the creation of effective prevention strategies and therapies. RECENT FINDINGS: The majority of allergen-specific IgE in humans appears to arise from antigen-experienced B cells that have already undergone class switch recombination to other antibody isotypes, such as IgG1, and can also be produced by cells class switching to IgE locally in the gastrointestinal tract. Allergen-specific IgG4 can have protective effects in individuals and is associated with tolerance. Regulatory B cells, which can produce allergen-specific IgG4, are reduced in food-allergic individuals and may also be an important component of tolerance. Therapeutic approaches that block the generation and action of IgE and that enhance tolerizing immune responses are being evaluated for the treatment of food allergy. SUMMARY: B cells play several roles in the development of food allergy versus tolerance. Their functions may translate into the care of food allergy as biomarkers or therapeutic targets and can be employed in other atopic diseases to better understand their pathogenesis and create new avenues for treatment.
Authors: Willem van de Veen; Barbara Stanic; Oliver F Wirz; Kirstin Jansen; Anna Globinska; Mübeccel Akdis Journal: J Allergy Clin Immunol Date: 2016-09 Impact factor: 10.793
Authors: Timothy J Looney; Ji-Yeun Lee; Krishna M Roskin; Ramona A Hoh; Jasmine King; Jacob Glanville; Yi Liu; Tho D Pham; Cornelia L Dekker; Mark M Davis; Scott D Boyd Journal: J Allergy Clin Immunol Date: 2015-08-22 Impact factor: 10.793
Authors: J J Heeringa; L Rijvers; N J Arends; G J Driessen; S G Pasmans; J J M van Dongen; J C de Jongste; M C van Zelm Journal: Allergy Date: 2018-03-30 Impact factor: 13.146
Authors: Brian P Vickery; Jing Lin; Michael Kulis; Zhiyan Fu; Pamela H Steele; Stacie M Jones; Amy M Scurlock; Gustavo Gimenez; Ludmilla Bardina; Hugh A Sampson; A Wesley Burks Journal: J Allergy Clin Immunol Date: 2012-11-27 Impact factor: 10.793